Calibrated  ||| S:0 E:11 ||| JJ
automated  ||| S:11 E:21 ||| JJ
thrombin  ||| S:21 E:30 ||| JJ
generation  ||| S:30 E:41 ||| NN
in  ||| S:41 E:44 ||| IN
paediatric  ||| S:44 E:55 ||| JJ
patients  ||| S:55 E:64 ||| NNS
with  ||| S:64 E:69 ||| IN
inflammatory  ||| S:69 E:82 ||| JJ
bowel  ||| S:82 E:88 ||| JJ
disease  ||| S:88 E:96 ||| NN
In  ||| S:96 E:99 ||| IN
adults ||| S:99 E:105 ||| NNS
,  ||| S:105 E:107 ||| ,
inflammatory  ||| S:107 E:120 ||| JJ
bowel  ||| S:120 E:126 ||| JJ
disease  ||| S:126 E:134 ||| NN
( ||| S:134 E:135 ||| -LRB-
IBD ||| S:135 E:138 ||| NNP
)  ||| S:138 E:140 ||| -RRB-
is  ||| S:140 E:143 ||| VBZ
associated  ||| S:143 E:154 ||| VBN
with  ||| S:154 E:159 ||| IN
an  ||| S:159 E:162 ||| DT
increased  ||| S:162 E:172 ||| JJ
risk  ||| S:172 E:177 ||| NN
of  ||| S:177 E:180 ||| IN
thromboembolic  ||| S:180 E:195 ||| JJ
complications ||| S:195 E:208 ||| NNS
.  ||| S:208 E:210 ||| .
The  ||| S:210 E:214 ||| DT
pathogenesis  ||| S:214 E:227 ||| NN
of  ||| S:227 E:230 ||| IN
IBD  ||| S:230 E:234 ||| NNP
is  ||| S:234 E:237 ||| VBZ
not  ||| S:237 E:241 ||| RB
really  ||| S:241 E:248 ||| RB
clear  ||| S:248 E:254 ||| JJ
and  ||| S:254 E:258 ||| CC
a  ||| S:258 E:260 ||| DT
high  ||| S:260 E:265 ||| JJ
thrombin  ||| S:265 E:274 ||| JJ
activity  ||| S:274 E:283 ||| NN
might  ||| S:283 E:289 ||| MD
contribute  ||| S:289 E:300 ||| VB
to  ||| S:300 E:303 ||| TO
disease  ||| S:303 E:311 ||| NN
progression ||| S:311 E:322 ||| NN
.  ||| S:322 E:324 ||| .
We  ||| S:324 E:327 ||| PRP
wanted  ||| S:327 E:334 ||| VBD
to  ||| S:334 E:337 ||| TO
see  ||| S:337 E:341 ||| VB
whether  ||| S:341 E:349 ||| IN
children  ||| S:349 E:358 ||| NNS
with  ||| S:358 E:363 ||| IN
IBD  ||| S:363 E:367 ||| NNP
have  ||| S:367 E:372 ||| VBP
a  ||| S:372 E:374 ||| DT
higher  ||| S:374 E:381 ||| JJR
thrombin  ||| S:381 E:390 ||| JJ
generation  ||| S:390 E:401 ||| NN
( ||| S:401 E:402 ||| -LRB-
TG ||| S:402 E:404 ||| NNP
) ||| S:404 E:405 ||| -RRB-
.  ||| S:405 E:407 ||| .
Plasma  ||| S:407 E:414 ||| JJ
samples  ||| S:414 E:422 ||| NNS
were  ||| S:422 E:427 ||| VBD
collected  ||| S:427 E:437 ||| VBN
of  ||| S:437 E:440 ||| IN
20  ||| S:440 E:443 ||| CD
patients  ||| S:443 E:452 ||| NNS
with  ||| S:452 E:457 ||| IN
IBD  ||| S:457 E:461 ||| NNP
and  ||| S:461 E:465 ||| CC
of  ||| S:465 E:468 ||| IN
60  ||| S:468 E:471 ||| CD
healthy  ||| S:471 E:479 ||| JJ
controls  ||| S:479 E:488 ||| NNS
( ||| S:488 E:489 ||| -LRB-
age  ||| S:489 E:493 ||| NN
range  ||| S:493 E:499 ||| NN
from  ||| S:499 E:504 ||| IN
10  ||| S:504 E:507 ||| CD
to  ||| S:507 E:510 ||| TO
19 ||| S:510 E:512 ||| CD
) ||| S:512 E:513 ||| -RRB-
.  ||| S:513 E:515 ||| .
TG  ||| S:515 E:518 ||| NNP
was  ||| S:518 E:522 ||| VBD
measured  ||| S:522 E:531 ||| VBN
by  ||| S:531 E:534 ||| IN
means  ||| S:534 E:540 ||| NNS
of  ||| S:540 E:543 ||| IN
Calibrated  ||| S:543 E:554 ||| NNP
automated  ||| S:554 E:564 ||| FW
thrombography  ||| S:564 E:578 ||| FW
( ||| S:578 E:579 ||| -LRB-
CAT ||| S:579 E:582 ||| NNP
) ||| S:582 E:583 ||| -RRB-
.  ||| S:583 E:585 ||| .
The  ||| S:585 E:589 ||| DT
disease  ||| S:589 E:597 ||| NN
activity  ||| S:597 E:606 ||| NN
was  ||| S:606 E:610 ||| VBD
estimated ||| S:610 E:619 ||| VBN
,  ||| S:619 E:621 ||| ,
using  ||| S:621 E:627 ||| VBG
the  ||| S:627 E:631 ||| DT
Pediatric  ||| S:631 E:641 ||| NNP
Crohn ||| S:641 E:646 ||| NNP
's  ||| S:646 E:649 ||| POS
Disease  ||| S:649 E:657 ||| NNP
Activity  ||| S:657 E:666 ||| NNP
Index  ||| S:666 E:672 ||| NNP
( ||| S:672 E:673 ||| -LRB-
PCDAI ||| S:673 E:678 ||| NNP
)  ||| S:678 E:680 ||| -RRB-
for  ||| S:680 E:684 ||| IN
Crohn ||| S:684 E:689 ||| NNP
's  ||| S:689 E:692 ||| POS
disease  ||| S:692 E:700 ||| NN
and  ||| S:700 E:704 ||| CC
the  ||| S:704 E:708 ||| DT
Pediatric  ||| S:708 E:718 ||| NNP
Ulcerative  ||| S:718 E:729 ||| NNP
Colitis  ||| S:729 E:737 ||| NNP
Disease  ||| S:737 E:745 ||| NNP
Activity  ||| S:745 E:754 ||| NNP
Index  ||| S:754 E:760 ||| NNP
( ||| S:760 E:761 ||| -LRB-
PUCAI ||| S:761 E:766 ||| NNP
)  ||| S:766 E:768 ||| -RRB-
for  ||| S:768 E:772 ||| IN
Ulcerative  ||| S:772 E:783 ||| NNP
Colitis ||| S:783 E:790 ||| NNP
.  ||| S:790 E:792 ||| .
In  ||| S:792 E:795 ||| IN
addition ||| S:795 E:803 ||| NN
,  ||| S:803 E:805 ||| ,
we  ||| S:805 E:808 ||| PRP
investigated  ||| S:808 E:821 ||| VBD
F1+F2 ||| S:821 E:826 ||| CD
,  ||| S:826 E:828 ||| ,
TAT ||| S:828 E:831 ||| NNP
,  ||| S:831 E:833 ||| ,
TFPI  ||| S:833 E:838 ||| NNP
and  ||| S:838 E:842 ||| CC
fibrinogen ||| S:842 E:852 ||| NN
.  ||| S:852 E:854 ||| .
There  ||| S:854 E:860 ||| EX
was  ||| S:860 E:864 ||| VBD
a  ||| S:864 E:866 ||| DT
significant  ||| S:866 E:878 ||| JJ
increase  ||| S:878 E:887 ||| NN
of  ||| S:887 E:890 ||| IN
endogenous  ||| S:890 E:901 ||| JJ
thrombin  ||| S:901 E:910 ||| JJ
potential  ||| S:910 E:920 ||| NN
( ||| S:920 E:921 ||| -LRB-
ETP ||| S:921 E:924 ||| NNP
) ||| S:924 E:925 ||| -RRB-
,  ||| S:925 E:927 ||| ,
lag  ||| S:927 E:931 ||| JJ
time  ||| S:931 E:936 ||| NN
and  ||| S:936 E:940 ||| CC
time  ||| S:940 E:945 ||| NN
to  ||| S:945 E:948 ||| TO
peak  ||| S:948 E:953 ||| VB
in  ||| S:953 E:956 ||| IN
patients  ||| S:956 E:965 ||| NNS
with  ||| S:965 E:970 ||| IN
IBD ||| S:970 E:973 ||| NNP
,  ||| S:973 E:975 ||| ,
while  ||| S:975 E:981 ||| IN
peak  ||| S:981 E:986 ||| NN
showed  ||| S:986 E:993 ||| VBD
no  ||| S:993 E:996 ||| DT
difference  ||| S:996 E:1007 ||| NN
to  ||| S:1007 E:1010 ||| TO
healthy  ||| S:1010 E:1018 ||| JJ
controls ||| S:1018 E:1026 ||| NNS
.  ||| S:1026 E:1028 ||| .
ETP  ||| S:1028 E:1032 ||| NNP
and  ||| S:1032 E:1036 ||| CC
F1+F2  ||| S:1036 E:1042 ||| CD
in  ||| S:1042 E:1045 ||| IN
children  ||| S:1045 E:1054 ||| NNS
with  ||| S:1054 E:1059 ||| IN
IBD  ||| S:1059 E:1063 ||| NNP
also  ||| S:1063 E:1068 ||| RB
showed  ||| S:1068 E:1075 ||| VBD
a  ||| S:1075 E:1077 ||| DT
significant  ||| S:1077 E:1089 ||| JJ
correlation  ||| S:1089 E:1101 ||| NN
with  ||| S:1101 E:1106 ||| IN
PCDAI  ||| S:1106 E:1112 ||| NNP
( ||| S:1112 E:1113 ||| -LRB-
PUCAI ||| S:1113 E:1118 ||| NNP
)  ||| S:1118 E:1120 ||| -RRB-
and  ||| S:1120 E:1124 ||| CC
fibrinogen ||| S:1124 E:1134 ||| NN
.  ||| S:1134 E:1136 ||| .
IBD  ||| S:1136 E:1140 ||| NNP
in  ||| S:1140 E:1143 ||| IN
children  ||| S:1143 E:1152 ||| NNS
is  ||| S:1152 E:1155 ||| VBZ
associated  ||| S:1155 E:1166 ||| VBN
with  ||| S:1166 E:1171 ||| IN
high  ||| S:1171 E:1176 ||| JJ
TG ||| S:1176 E:1178 ||| NNP
,  ||| S:1178 E:1180 ||| ,
but  ||| S:1180 E:1184 ||| CC
this  ||| S:1184 E:1189 ||| DT
seems  ||| S:1189 E:1195 ||| VBZ
to  ||| S:1195 E:1198 ||| TO
be  ||| S:1198 E:1201 ||| VB
caused  ||| S:1201 E:1208 ||| VBN
mainly  ||| S:1208 E:1215 ||| RB
by  ||| S:1215 E:1218 ||| IN
the  ||| S:1218 E:1222 ||| DT
inflammatory  ||| S:1222 E:1235 ||| JJ
process  ||| S:1235 E:1243 ||| NN
and  ||| S:1243 E:1247 ||| CC
not  ||| S:1247 E:1251 ||| RB
by  ||| S:1251 E:1254 ||| IN
any  ||| S:1254 E:1258 ||| DT
individual  ||| S:1258 E:1269 ||| JJ
disposition ||| S:1269 E:1280 ||| NN
.  ||| S:1280 E:1282 ||| .
